Elected officials, policy analysts, and business leaders came together in Chicago on October 23 for a National Symposium to discuss the pros and cons of prescription drug importation. Video clips of speakers and a video news release are now available online.
| What’s Wrong with Importing Drugs from Canada? (complete transcript – PDF – 343 kb) |
|---|
| Video News Release |
|---|
| Speakers (in alpha order) |
|---|
| Joseph L. Bast President The Heartland Institute Introduction (transcript) |
| Stephen Entin President Institute for Research on the Economics of Taxation The Dubious Economics of Drug Importation |
| Robert Goldberg Senior Fellow Manhattan Institute Small Gains, Enormous Risks |
| John Graham Director of Pharmaceutical Policy Research Fraser Institute A Canadian Economist’s Perspective |
| Sean Heather Executive Director of Congressional Public Affairs U.S. Chamber of Commerce It’s Really About Spending, Not Safety |
| Hon. Chris Lauzen Illinois State Senator Don’t Just Stand There, Do Something! |
| David Miller President Illinois Biotechnology Industry Organization The Danger of Unknown and Unknowable Costs |
| Hon. Steven Rauschenberger Illinois State Senator Not a Solution to State Budget Problems |
| Grace-Marie Turner President The Galen Institute Costs, Compulsory Licensing, and Counterfeiting |
| Appendices
Appendix 1: The $91 Million Mistake |
The event, hosted by The Heartland Institute and cosponsored by the Illinois Manufacturers Association, Illinois Retail Merchants Association, and U.S. Chamber of Commerce, was the first open-to-the-public discussion of Illinois Governor Rod Blagojevich’s proposal to import Canadian prescription drugs to lower the state’s spending on Medicaid and public employee health benefits.
The following links provide additional information on the topic, including materials distributed at the Symposium.
Diane Carol Bast is a former member of The Heartland Institute’s board of directors.
